Enzo Life Sciences Exendin-4 GLP-1 receptor agonist
Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.
Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.
Phone: 02 4575 0309
Abcalis Multiclonal Recombinant Secondary Antibodies
Multiclonals consist of defined mixtures of carefully selected individual recombinant monoclonal...
GeneTex ion channel antibodies
GeneTex offers a wide selection of antibodies to support ion channel research, with IHC-validated...
AMSL Scientific CompactDry Total Count Rapid (TCR)
Next-day results are available with CompactDry TCR for total viable counts — an...
Learn More
I am interested in Enzo Life Sciences Exendin-4 GLP-1 receptor agonist .
Complete the form and a supplier representative will be in touch.
